Skip to main content
. Author manuscript; available in PMC: 2020 Apr 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2018 Jun 11;17(5):968–975.e5. doi: 10.1016/j.cgh.2018.05.046

Table 2.

Characteristics of participants with normal liver, steatosis, and F2 fibrosis, Cameron County Hispanic Cohort

Parameters Healthya Estimateb (95% CI) Steatosis Estimate (95% CI) Fibrosis Estimate (95% CI) p-value

Age (years) 51.8 (48.0 - 55.6) 52.5 (48.5 - 56.5) 45.1 (38.9 - 51.4) 0.1245
Male Sex 42.2 (33.4 - 51.0) 39.5 (28.0 - 51.0) 55.9 (39.6 - 72.3) 0.2908
No Insurance (< 65 years) 57.5 (46.8 - 68.3) 61.8 (49.9 - 73.7) 68.6 (49.1 - 88.2) 0.5859
Born in US 28.5 (20.3 - 36.7) 22.9 (14.4 - 31.3) 35.2 (15.5 - 55.0) 0.4247
Family History of Diabetes 29.1 (20.5 - 37.7) 33.7 (22.7 - 44.7) 21.6 (6.6 - 36.6) 0.4243
Diabetesc 23.2 (13.7 - 32.7) 36.6 (26.8 - 46.5) 27.5 (12.0 - 42.9) 0.1581
Fasting Glucose (mg/dL) 104.0 (97.4 - 110.6) 124.8 (107.8 - 141.7) 111.9 (87.9 - 135.8) 0.0839
Hemoglobin A1C (%) 6.1 (5.8 - 6.5) 6.7 (6.2 - 7.2) 6.4 (5.7 - 7.2) 0.1951
Insulin 9.4 (8.3 - 10.5) 14.7 (12.6 - 16.9) 10.5 (7.6 - 13.4) 0.0001*
HOMA-IR 2.4 (2.1 - 2.7) 4.4 (3.5 - 5.3) 2.8 (1.8 - 3.8) 0.0003*
Hypertensiond 40.2 (30.1 - 50.2) 43.0 (27.6 - 58.4) 40.1 (20.1 - 60.1) 0.9465
Systolic BP (mmHg)e 117.9 (114.4 - 121.3) 120.2 (116.5 - 123.8) 116.5 (108.0 - 125.1) 0.5526
Diastolic BP (mmHg) 70.5 (68.8 - 72.3) 73.1 (71.2 - 75.0) 71.2 (66.6 - 75.9) 0.0931
Triglycerides (mg/dL) 127.7 (116.4 - 139.0) 161.9 (148.3 - 175.6) 134.2 (94.5 - 173.9) 0.0009*
Total Cholesterol (mg/dL) 178.5 (170.0 - 187.0) 180.6 (173.5 - 187.8) 172.4 (155.5 - 189.4) 0.6737
LDL Cholesterol (mg/dL) 107.3 (101.2 - 113.3) 104.5 (97.9 - 111.1) 97.4 (87.2 - 107.7) 0.2879
HDL Cholesterol, mean (mg/dL) 47.7 (45.7 - 49.8) 41.9 (40.1 - 43.6) 46.1 (42.1 - 50.2) <0.0001*
AST (units/L) 21.3 (19.6 - 23.0) 27.7 (22.0 - 33.5) 34.2 (19.5 - 48.9) 0.0313
ALT (units/L) 29.3 (26.2 - 30.3) 44.5 (32.4 - 56.6) 39.5 (28.7 - 50.4) 0.0053*
AST/ALT Ratio 0.77 (0.73 - 0.82) 0.72 (0.61 - 0.83) 0.83 (0.74 - 0.92) 0.2464
Obese (BMI ≥ 30) 29.5 (21.4 - 37.5) 56.2 .0(45 - 67.3) 39.1 (22.9 - 55.3) 0.0006*
BMI (kg/m2) 28.6 (27.9 - 29.4) 31.5 (30.7 - 32.4) 28.1 (26.2 - 29.9) <0.0001*
Elevated waist circumferencef 57.2 (47.8 - 66.5) 77.0 (65.8 - 88.2) 58.5 (40.6 - 76.4) 0.0234
Waist Circumference (cm) 97.9 (95.5 - 100.3) 104.8 (102.6 - 106.9) 98.7 (93.9 - 103.5) <0.0001*
Platelet count (103/μL) 236 (224 - 248) 241.4 (228.3 - 254.4) 219.2 (200.5 - 238.0) 0.1374
Albumin (mg/dL) 3.9 (3.8 - 4.0) 4.9 (3.9 - 4.0) 3.9 (3.8 - 4.0) 0.5477
Total Bilirubin (mg/dL) 2.2 (0.0 - 5.2) 0.7 (0.4 - 1.0) 0.7 (0.4 - 1.0) 0.5936
Anti-HCV Positive 0.3 (0.0 - 1.0) 2.6 (0.0 - 5.3) 5.7 (0.0 - 12.5) 0.0157
HBsAg Positive 0.0 (0.0 - 0.0) 0.0 (0.0 - 0.0) 0.0 (0.0 - 0.0) N/A
Drinks per week 1.8 (0.7 - 2.9) 2.1 (0.8 - 3.4) 5.4 (1.8 - 8.9) 0.1737
Heavy Drinkingg 2.5 (0.0 - 6.9) 1.8 (0.0 - 4.5) 12.4 (0.0 - 27.1) 0.0639

Abbreviations: CI, confidence interval; HOMA-IR, homeostatis model of insulin resistance; LDL, low-density lipoprotein; HDL, high-density lipoprotein; AST, aspartate aminotransferase; ALT, alanine aminotransferase; BMI, Body Mass Index; Anti-HCV, hepatitis C Virus antibody; HBsAg, Hepatitis B Surface Antigen.

Note. Statistical tests significant at the 5% level after correction for false discovery rate are marked with an asterisk.

a

Healthy indicates no evidence of steatosis and liver stiffness ≤ 1.34; steatosis indicates evidence of steatosis and liver stiffness ≤ 1.34 m/s; fibrosis indicates liver stiffness > 1.34 m/s with or without steatosis

b

For continuous variables, mean; for categorical variables, proportion. P-values calculated from ANOVA for continuous variables and from Rao-Scott χ2 test for categorical variables

c

According to American Diabetes Association 2010 Diagnostic Guidelines

d

Systolic Blood Pressure > 135 or Diastolic Blood Pressure > 85 or taking antihypertensive medication.

e

Blood pressure analyses are adjusted for self-reported use of antihypertensive medication

f

Defined as waist circumference > 102 for men and > 88 for women

g

Defined as self-reported consumption of >21 drinks per week for men, and >14 drinks per week for women.